Regular users of medicines containing codeine are being invited to participate in a study on how the rescheduling will affect them
A University of Tasmania research project is aiming to understand how codeine rescheduling will impact people who use the product, inviting people who regularly use codeine to participate in the study.
“There are quite a number of people in the community who use codeine for chronic, non-cancer pain,” University of Tasmania School of Psychology PhD student Jacqui McCoy says.
“The aim of this project is to better understand the impact of this policy change on people who regularly use codeine, their needs and how they will manage their pain.”
In particular, researchers want to know how people use, and access, codeine-based products both before and after February 1 next year.
Participants will be asked how they use codeine to manage their pain, and importantly, how they access health services following the rescheduling.
“We will examine the impact on people in rural and remote communities, and those on low incomes who may not be able to afford to visit the GP,” Ms McCoy says.
The research team includes the University of Tasmania’s School of Psychology Jacqui McCoy, supervisor Associate Professor Raimondo Bruno and Dr Suzanne Nielsen from the University of New South Wales.
People interested in participating in the study can visit https://redcap.utas.edu.au/surveys/?s=N7PFFR9D77